Sleep and Breathing

, Volume 15, Issue 1, pp 35–47 | Cite as

Coupling changes in cortical and pontine sigma and theta frequency oscillations following monoaminergic lesions in rat

  • Srdjan Kesic
  • Aleksandar Kalauzi
  • Miodrag Radulovacki
  • David W. Carley
  • Jasna Saponjic
Original Article



Sigma and theta frequency electroencephalogram (EEG) oscillations exhibit substantial and well-recognized shifts with transitions across sleep and wake states. We aimed in this study to test the changes in coupling between these characteristic oscillations of non-rapid-eye-movement (NREM)/rapid-eye-movement (REM) sleep within and between cortical and pontine EEGs following monoaminergic lesion, by using the Pearson's product-moment correlation coefficients.


Experiments were performed in 14 adult, male Sprague Dawley rats chronically instrumented for sleep recording. We lesioned the dorsal raphe nucleus axon terminals in four rats using PCA neurotoxin (p-chloroamphetamine; Sigma-Aldrich, MO) administered as two intraperitoneal (IP) injections (6 mg/kg) 24 h apart. Lesioning of locus coeruleus axon terminals was performed in five rats using DSP-4 neurotoxin (N-2-chloroethyl-N-ethyl-2-bromobenzilamine; Sigma-Aldrich, MO) in a single IP dose of 50 mg/kg.

Results & Conclusions

Our previous study [Saponjic et al., Physiol Behav 90:1–10, 2007] demonstrated that these systemically induced monoaminergic lesions failed to produce significant changes in sleep/wake distribution from control conditions. The present study, by using spectral analysis and by examining the Pearson's correlation coefficients and their approximate probability density (APD) distribution profiles in control and lesion condition, demonstrates significant augmentation of the sigma/theta coupling strength, an inversion of cortical sigma/theta coupling direction and emergence of an additional sigma/theta coupling “mode” specific to the post-lesion state only within the cortex. By using the Pearson's correlation coefficients and their APD profiles, instead of classical sleep/wake distribution analysis, as a measure of direction and strength of sigma/theta coupling within and between cortex and pons, we were able to uncover the impact of a tonically decreased level of brain monoamines as altered strength and mode of coupling between sigma and theta oscillations. Specifically, a new mode of sigma/theta coupling emerged following lesion, which was specific to NREM sleep, suggests that loss of monoaminergic signaling interferes with NREM sleep consolidation. Our results also indicate an importance of monoamines in control of the sleep spindle and theta rhythm generators.


EEG Theta Sigma Monoamines Neurotoxin Pearson's coefficient of correlation 



This work was supported by Serbian Ministry of Science and Technological Development Grant 143005, 143027, and NIH Grant AG01630.


  1. 1.
    Saponjic J, Radulovacki M, Carley DW (2007) Monoaminergic system lesions increase post-sigh respiratory pattern disturbance during sleep in rats. Physiol Behav 90:1–10PubMedCrossRefGoogle Scholar
  2. 2.
    Uchida S, Maloney T, Feinberg I (1994) Sigma (12–16 Hz) and beta (20–28 Hz) EEG discriminate NREM and REM sleep. Brain Res 659:243–248PubMedCrossRefGoogle Scholar
  3. 3.
    De Gennaro L, Ferrara M (2003) Sleep spindles: an overview. Sleep Med Rev 7:423–440PubMedCrossRefGoogle Scholar
  4. 4.
    Steriade M, McCormick DA, Sejnowski TJ (1993) Thalamocortical oscillations in the sleeping and aroused brain. Science 262:679–685PubMedCrossRefGoogle Scholar
  5. 5.
    Steriade M, Llinas RR (1998) The functional states of the thalamus and the associated neuronal interplay. Physiol Rev 68:649–742Google Scholar
  6. 6.
    Steriade M (2003) The corticothalamic system in sleep. Front Biosci 8:878–899CrossRefGoogle Scholar
  7. 7.
    Vertes RP (1984) Brainstem control of the events of REM sleep. Prog Neurobiol 22:241–288PubMedCrossRefGoogle Scholar
  8. 8.
    Datta S, Maclean RR (2007) Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neurosci Biobehav Rev 31:775–824PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Vinogradova OS (1995) Expression, control, and probable functional significance of the neuronal theta-rhythm. Prog Neurobiol 45:523–583PubMedCrossRefGoogle Scholar
  10. 10.
    Steriade M, Gloor P, Llinas RR, Lopes de Silva FH, Mesulam MM (1990) Report of IFCN committee on basic mechanisms. Basic mechanisms of cerebral rhythmic activities. Electroencephalogr Clin Neurophysiol 76:481–508PubMedCrossRefGoogle Scholar
  11. 11.
    Podol’skii IY, Vorob’ev VV, Belova NA (2001) Long-term changes in hippocampus and neocortex EEG spectra in response to pharmacological treatments affecting the cholinergic system. Neurosci Behav Physiol 31:589–595PubMedCrossRefGoogle Scholar
  12. 12.
    Timofeeva OA, Gordon CJ (2001) Changes in EEG power spectra and behavioral states in rats exposed to the acetylcholinesterase inhibitor chlorpyrifos and muscarinic agonist oxotremorine. Brain Res 893:165–177PubMedCrossRefGoogle Scholar
  13. 13.
    Timofeeva OA, Gordon CJ (2002) EEG spectra, behavioral states and motor activity in rats exposed to acetylcholinesterase inhibitor chlorpyrifos. Pharmacol Biochem Behav 72:669–679PubMedCrossRefGoogle Scholar
  14. 14.
    Graeff FG, Quintero S, Gray JA (1980) Median raphe stimulation, hippocampal theta rhythm and threat-induced behavioral inhibition. Physiol Behav 25:253–261PubMedCrossRefGoogle Scholar
  15. 15.
    Hajos M, Hoffmann WE, Robinson DD, Yu JH, Hajos KE (2003) Norepinephrine but not serotonin reuptake inhibitors enhance theta and gamma activity of the septo-hippocampal system. Neuropsychopharmacol 28:857–864Google Scholar
  16. 16.
    Kantor S, Jakus R, Balogh B, Benko A, Bagdy G (2004) Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505. B J Pharmacol 142:1332–1342CrossRefGoogle Scholar
  17. 17.
    Carley DW, Trbovic SM, Bozanich A, Radulovacki M (1997) Cardiopulmonary control in sleeping Sprague-Dawley rats treated with hydralazine. J Appl Physiol 83:1954–1961PubMedGoogle Scholar
  18. 18.
    Carley DW, Radulovacki M (1999) Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat. Am J Respir Crit Care Med 160:1824–1829PubMedCrossRefGoogle Scholar
  19. 19.
    Mamounas LA, Molliver ME (1988) Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp Neurol 102:23–36PubMedCrossRefGoogle Scholar
  20. 20.
    Fritschy JM, Grzanna R (1989) Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Neurosci 30:181–197CrossRefGoogle Scholar
  21. 21.
    Ross SB (1976) Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart. Br J Pharmacol 58:521–527PubMedCrossRefGoogle Scholar
  22. 22.
    Sanders-Bushand E, Steranka LR (1978) Immediate and long-term effects of p-chloroamphetamine on brain amines. Ann N Y Acad Sci 305:208–321CrossRefGoogle Scholar
  23. 23.
    Manns ID, Alonso A, Jones BE (2000) Discharge properties of juxtacellularly labeled and immunohistochemically identified cholinergic basal forebrain neurons recorded in association with the electroencephalogram in anesthetized rats. J Neurosci 20:1505–1518PubMedGoogle Scholar
  24. 24.
    Steriade M, Dossi RC, Pare D, Oakson G (1991) Fast oscillations (20–40 Hz) in thalamocortical systems and their potentiation by mesopontine cholinergic nuclei in the cat. Proc Natl Acad Sci U S A 88:4396–4400PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Holschneider DP, Leuchter AF, Walton NY, Scremin OU, Treiman DM (1997) Changes in cortical EEG and cholinergic function in response to NGF in rats with nucleus basalis lesions. Brain Res 765:228–237PubMedCrossRefGoogle Scholar
  26. 26.
    Abe K, Horiuchi M, Yoshimura K (1997) Potentiation by DSP-4 of EEG slowing and memory impairment in basal forebrain-lesioned rats. Eur J Pharmacol 321:149–155PubMedCrossRefGoogle Scholar
  27. 27.
    Buzsaki G, Bickford RG, Ponomareff G, Thal LJ, Mandel R, Gage FH (1988) Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci 8:4007–4026PubMedGoogle Scholar
  28. 28.
    Buzsaki G, Gage FH (1989) The cholinergic nucleus basalis: a key structure in neocortical arousal. Exs 57:159–171PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Srdjan Kesic
    • 1
  • Aleksandar Kalauzi
    • 2
  • Miodrag Radulovacki
    • 3
    • 4
  • David W. Carley
    • 4
  • Jasna Saponjic
    • 1
  1. 1.Department of Neurobiology, Institute for Biological Research - Sinisa StankovicUniversity of BelgradeBelgradeSerbia
  2. 2.Department for Life SciencesInstitute for Multidisciplinary ResearchBelgradeSerbia
  3. 3.Department of PharmacologyUniversity of IllinoisChicagoUSA
  4. 4.Center for Narcolepsy, Sleep and Health ResearchUniversity of IllinoisChicagoUSA

Personalised recommendations